verified SJR 3,362 · Q1 • database Scopus / SJR & Web of Science indexed

Switzerland

workspace_premium Q1 — Pharmacology (medical) lock Subscription Unclaimed

Drugs

Drugs is a journal indexed in SJR in Pharmacology (medical) with an H index of 201. It has a price of 3790 €. It has an SJR impact factor of 3,362 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 3,362.

Drugs focuses its scope in these topics and keywords: review, therapeutic, patients, concepts, intranasal, established, granulomatosis, anticoagulants, iontophoretic, complications, ...

ISSN: 0012-6667

Category: Pharmacology (medical)

Indexation: verifiedScopus / SJR verifiedWeb of Science

Unclaimed profile — some fields may be incomplete.

open_in_new Portal NPD menu_book Guidelines NPD

schedule Datos CoP · solo campos en BD

SJR Impact Factor trending_up

3,362 Q1

H-index 201

Tasa de Aceptación pie_chart

21% Selectiva

Fuente Acceptance_Rate

Tiempo a publicación hourglass_top

NPD

Campo Sin dato

Coste de Publicación (APC) payments

3.790 € Subscription

Ruta Non-OA 0 €

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR Web of Science

SJR Impact

3,362

H-index

201

Docs (year)

127

Docs 3y

457

Total refs

8620

Cites 3y

5488

Citable 3y

433

Cites/Doc 2y

11.29

Ref/Doc

67.87

Immediate OA

3790 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Bacteria-Triggered Reactive Arthritis

Vildagliptin: A Review of Its Use in Type 2 Diabetes Mellitus

Clinical Pharmacokinetics of Felodipine

Clinical Aspects of Invasive Candidiasis in Paediatric Patients

Cidofovir

Choosing the Right beta-Blocker

Cefodizime

Cefepime

Caspofungin

Carvedilol

Betrixaban for Extended Venous Thromboembolism Prophylaxis in High-Risk Hospitalized Patients: Putting the APEX Results into Practice

Benefit:Risk Profile of Budesonide in Obstructive Airways Disease

SHOW MORE ARTICLES

Basiliximab

Abiraterone Acetate: A Review in Metastatic Castration-Resistant Prostrate Cancer

Asfotase Alfa: A Review in Paediatric-Onset Hypophosphatasia

As-needed ICS-LABA in Mild Asthma: What Does the Evidence Say?

Argatroban

Are All Dopamine Agonists Essentially the Same?

Antifungal Resistance Trends Towards the Year 2000

Anthelmintics

Advanced Glycation Endproduct Crosslinking in the Cardiovascular System

Adefovir Dipivoxil

Acute Otitis Media in Sweden

Acotiamide: First Global Approval

FAQS

In Country of Papers you can find SJR impact factor and other metrics to help you decide on a Journal.